SNY

Sanofi SNY

NasdaqLarge CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$43.63B

Quarter to Dec 31

Net income

$7.81B

Quarter to Dec 31

Free cash flow

$7.21B

Quarter to Dec 31

Operating margin

14.5%

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$8.19B total
DODGE & COX
$1.20B-4.8%
MORGAN STANLEY
$456.57M-14.5%
Fisher Asset Management, LLC
$453.35M-7.1%
BANK OF AMERICA CORP /DE/
$341.65M-15.6%
Invesco Ltd.
$290.04M+2.7%
JPMORGAN CHASE & CO
$285.50M+17.4%
Mondrian Investment Partners LTD
$235.59M+9.6%
BRANDES INVESTMENT PARTNERS, LP
$176.46M+11.1%
FEDERATED HERMES, INC.
$164.23M-19.0%
Boston Partners
$164.04M+6.8%
MILLENNIUM MANAGEMENT LLC
$159.03M+8.3%
FMR LLC
$156.92M-8.3%
ENVESTNET ASSET MANAGEMENT INC
$145.16M-11.9%
WELLS FARGO & COMPANY/MN
$139.66M-4.1%
RAYMOND JAMES FINANCIAL INC
$137.06M-15.7%
ROYAL BANK OF CANADA
$135.26M+0.5%
GOLDMAN SACHS GROUP INC
$127.76M+16.0%
BARCLAYS PLC
$114.50M+13.9%
BARROW HANLEY MEWHINNEY & STRAUSS LLC
$114.37M-54.5%
Regal Partners Ltd
$113.22M+4.3%
EQUITY INVESTMENT CORP
$111.00M-2.3%
BALYASNY ASSET MANAGEMENT L.P.
$102.62M+188.5%
Pacer Advisors, Inc.
$99.21M-29.2%
AMERICAN CENTURY COMPANIES INC
$94.08M+2.7%
LPL Financial LLC
$90.80M-3.5%
See all 727 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Loading ratio trend…

SNY key financials by period

Reported revenue, net income and operating margin by fiscal year, from Sanofi's annual filings on SEC EDGAR.

Sanofi reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$43.6B$7.8B14.5%
FY 2024$41.1B$5.6B17.6%
FY 2023$37.8B$5.4B18.4%
FY 2022$37.7B$8.4B27.0%
FY 2021$37.8B$6.2B21.5%
FY 2020$36.0B$12.3B39.2%
Source: SNY filings on SEC EDGAR →

Congress trading in SNY

12 transactions in SNY reported by 6 members of Congress under the STOCK Act, most recent trade Sep 11, 2025. Reported transactions, not recommendations.

All Congress stock trades →

About Sanofi (SNY): stock profile, AI score and financials

Sanofi (SNY) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. SNY is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (FY 2025), Sanofi reports quarterly revenue of $43.6B, net income of $7.8B, an operating margin of 14.5%. Top institutional holders of SNY by reported 13-F value include DODGE & COX, MORGAN STANLEY, Fisher Asset Management, based on the most recent SEC filings. SNY trades on the Nasdaq exchange and files with the SEC under CIK 1121404. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SNY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Sanofi directly from SEC EDGAR.

SEC EDGAR: CIK 1121404 →